A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application

BACKGROUND: Oncology clinical trials can lead to relevant financial savings in drug acquisition for healthcare providers. Considerable methodological heterogeneity is observed among previous studies estimating these savings. METHODS: We developed a methodology to estimate the economic benefit obtain...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Sánchez, Sebastián, Collado-Borrell, Roberto, González-Haba, Eva, Revuelta-Herrero, José Luis, Escudero-Vilaplana, Vicente, Marzal-Alfaro, María Belén, Sánchez-Fresneda, María Norberta, Mur-Mur, Ana, Herranz, Ana, Martín, Miguel, Sanjurjo, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213877/
https://www.ncbi.nlm.nih.gov/pubmed/35756684
http://dx.doi.org/10.3389/fonc.2022.889575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213877/
https://www.ncbi.nlm.nih.gov/pubmed/35756684
http://dx.doi.org/10.3389/fonc.2022.889575

Ejemplares similares